Global health body says benefits of Convidecia vaccine far outweigh risks The World Health...
Socio-Economic Developments
Turkiye’s Daily COVID-19 Cases Fall Below 1,000 For First...
Health Ministry confirms 922 new infections, 3 related deaths in last 24 hours Coronavirus...
Mucosal COVID Vaccine Candidate Powerfully Protective in Macaques
A recent research paper posted to the bioRxiv* preprint server illustrated the protective efficacy...
Model Predicts Scenarios That Reveal The Benefit Of Updating...
In a recent study posted to the bioRxiv* preprint server, scientists analyzed the necessity of...
Immunogenicity Predictions Reveal SARS-CoV-2 CD8+ T-cell Epitopes
In a recent study posted to the bioRxiv* pre-print server, researchers identified several new...
World Unprepared for COVID-19 and Remains Ill-equipped for Next...
The updated report found the world’s COVID-19 response remains “insufficient.” The world was...
CDC Signs Off on Booster Shots for Children Ages 5 to 11
Less than 30% of children ages 5 to 11 years old have been fully vaccinated. The Centers for...
FDA Advisers to Meet to Discuss COVID-19 Shots for Kids...
The FDA said that it expects for its advisers to meet in June. In the wake of Pfizer’s new...
Pfizer 3-dose COVID Vaccine 80% Effective Against Symptomatic...
Vaccines for youngest children are expected to be available in June or July In long-awaited data...
COVID-19 Measures Lifted in Most European Countries
Many people hospitalized, died in many European countries since beginning of pandemic Some European...
Life
WHO Validates China’s Convidecia as 11th Vaccine for COVID-19
Global health body says benefits of Convidecia vaccine far outweigh risks The World Health...
Vaccination
WHO Validates China’s Convidecia as 11th Vaccine for COVID-19
Global health body says benefits of Convidecia vaccine far outweigh risks The World Health...
Pharma
EXCLUSIVE Pardes To Go Public, Says COVID-19 Antiviral Pill Does...
Dec 21 (Reuters) – Pardes Biosciences on Tuesday said early human testing shows that its...
